IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
Treatment Strategies for ROS1 Non-Small Cell Lung Cancer
February 06, 2018 | Online


During this webinar we will: 

  • review ROS1 epidemiology;
  • appraise optimal testing;
  • review treatment results with different ROS inhibitors;
  • identify the mechanisms of acquired resistance to ROS1 inhibitors; and
  • look forward to the potential next steps in the management of this disease.

What you should expect to learn

Learning Objectives:

  • Demonstrate new targetable molecular subtype, ROS1, a distinct group of patients for which new treatments are now available.
  • Appraise optimal molecular testing to determine the profile of individual patients and selection for specific, active therapeutic approaches.
  • Identify the mechanisms of acquired resistance to ROS1 inhibitors.

Federico Cappuzzo, MD

Director of Medical Oncology
Department of Medical 
Oncology and Hematology
Ospedale Santa Maria delle Croci
Ravenna, Italy


Enriqueta Felip, MD

Chief Thoracic Medical Oncology
Associate Professor,
Vall d'Hebron University Hospital
Barcelona, Spain